Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02244099 · ClinicalTrials.gov registry record · NA
Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic
A NA study of Anxiety and Chronic Pain, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 96
- Enrollment target
- 1
- Study location
NCT02244099: Completed NA study of Anxiety and Chronic Pain, sponsored by Ohio State University.
NCT02244099 is a NA study of Anxiety and Chronic Pain that has completed, run by Ohio State University. The registered enrollment target is 96 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02244099, a NA study of Anxiety and Chronic Pain, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to characterize and improve controlled substance, carisoprodol and tramadol use in an internal medicine residents' clinic. Specific objectives of this study include: * To measure the adherence to a controlled substance treatment agreement (CSTA) before and after implementation of a population management intervention * To determine the number of patients on a CSTA with a discrepancy identified on a urine drug screen or an Ohio Automated Rx Reporting System (OARRS) report * To track the number of patients on a morphine equivalent dose (MED) of ≥ 80 mg/day before and after implementation of a review intervention * To characterize the healthcare utilization of patients taking controlled substances, carisoprodol, or tramadol by tracking the mean number of ED visits, hospital admissions, telephone calls, and clinic office visits during a 6 month period
Primary Outcome
To measure the adherence to a controlled substance treatment agreement (CSTA) before and after implementation of a population management intervention
Conditions Studied
Interventions
- OTHER Controlled Substance
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-03 |
| Phase | NA |
What the finished NCT02244099 record still lists
NCT02244099 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (78% lower).
The record links to 3 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Controlled Substance is the first listed.
NCT02244099 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02244099 about?
NCT02244099 is a clinical study titled "Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic". The purpose of this study is to characterize and improve controlled substance, carisoprodol and tramadol use in an internal medicine residents' clinic. Specific objectives of this study include: * To measure the adherence to a controlled substance treatment agreement (CSTA) before and after impleme...
What is the current status of trial NCT02244099?
This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2014-09. Estimated completion is 2015-03.
What conditions does trial NCT02244099 study?
This clinical trial studies the following conditions: Anxiety, Chronic Pain, Opioid Use, Unspecified.
What interventions are being tested in trial NCT02244099?
The interventions under investigation include: Controlled Substance (OTHER).
Who is sponsoring clinical trial NCT02244099?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02244099 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02244099's enrollment target sits among peer trials
96 178th of 364 higher than 185 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia